Iatrogenic vitamin D toxicity in an infant – a case report and review of literature.

Public concern over vitamin D deficiency has led to widespread use of over the counter (OTC) vitamin D (-D 3 or -D 2 ) supplements, containing up to 10,000 IU/unit dose (400 IU = 10 μg). Overzealous use of such supplements can cause hypercalcemia due to vitamin D toxicity. Infants are particularly vulnerable to toxicity associated with vitamin D overdose. OTC supplements are not subject to stringent quality control regulations from FDA and high degree of variability in vitamin D content in OTC pills has been demonstrated. Other etiologies of vitamin D induced hypercalcemia include hyperparathyroidism, granulomatous malignancies like sarcoidosis and mutations in the CYP24A1 gene. The differential diagnosis of hypercalcemia should include iatrogenic and genetic etiologies. C24-hydroxylation and C3-epimerization are two important biochemical pathways via which 25-hydroxyvitamin D 3 (25(OH)D 3 ) is converted to its metabolites, 24,25-dihydroxyvitamin D 3 (24,25(OH) 2 D 3 ) or its C3 epimer, 3-epi-25-OH-D 3 respectively. Mutations in the CYP24A1 gene cause reduced serum 24,25(OH) 2 D 3 to 25(OH)D 3 ratio (<0.02), elevated serum 1,25-dihydroxyvitamin D (1,25(OH) 2 D 3 ), hypercalcemia, hypercalciuria and nephrolithiasis. Studies in infants have shown that 3-epi-25(OH)D 3 can contribute 9–61.1% of the total 25(OH)D 3 . Therefore, measurements of parathyroid hormone (PTH) and vitamin D metabolites 25(OH)D 3 , 1,25(OH) 2 D 3 , 3-epi-25(OH)D 3 and 24,25(OH) 2 D 3 are useful to investigate whether the underlying cause of vitamin D toxicity is iatrogenic versus genetic. Here we report a case of vitamin D 3 associated toxicity in a 4-month-old female who was exclusively breast-fed and received an oral liquid vitamin D 3 supplement at a dose significantly higher than recommended on the label. The vitamin D 3 content of the supplement was threefold higher (6000 IU of D/drop) than listed on the label (2000 IU). Due to overdosing and higher vitamin D 3 content, the infant received ∼50,000 IU/day for two months resulting in severe hypercalcemia, hypercalciuria and nephrocalcinosis. We also review the relevant literature on vitamin D 3 toxicity in this report. [ABSTRACT FROM AUTHOR]